Skip to content
value.today
Sight Sciences, Inc. logo

Sight Sciences, Inc.

🇺🇸 Menlo Park, California, USABiotechnologyFounded 2010
Total raised
$111 M
5 rounds on record
Latest round
$23 M
Nov 2020
First round on record
Oct 2015
Today
Went public
See the company page

Sight Sciences, Inc. is listed today as Sight Sciences, Inc.: market value, financials and filings are on its company page.

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Sight Sciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2020$23 MNo. 5$10 to $50 million

Sight Sciences, Inc.: Raise no. 5, Nov 2020

Investors in this round

4 investors had bought by the notice of Dec 10, 2020: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Sight Sciences, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$23 M of $23 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jesse Selnick · Executive Officer
  • Paul Badawi · Executive Officer, Director
  • Andrew Offer · Director
  • David Badawi · Director
  • Don Zurbay · Director
  • Erica Rogers · Director
  • Mack Hicks · Director
  • Staffan Encrantz · Director
  • Valeska Schroeder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jesse Selnick, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 10, 2020. Read the notice at the SEC.

equitySEC
Mar 2020$30 MNo. 4$10 to $50 million

Sight Sciences, Inc.: Raise no. 4, Mar 2020

Investors in this round

0 investors had bought by the notice of Apr 14, 2020: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Sight Sciences, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$30 M of $31 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jesse Selnick · Executive Officer
  • Paul Badawi · Executive Officer, Director
  • Carter Meyer · Director
  • David Badawi · Director
  • Erica Rogers · Director
  • Mack Hicks · Director
  • Staffan Encrantz · Director
  • Valeska Schroeder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jesse Selnick, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Apr 14, 2020. Read the notice at the SEC.

equitySEC
Aug 2019$31 MNo. 3$10 to $50 million

Sight Sciences, Inc.: Raise no. 3, Aug 2019

Investors in this round

2 investors had bought by the notice of Sep 10, 2019: 2 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Sight Sciences, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$31 M of $32 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$500,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jesse Selnick · Executive Officer
  • Paul Badawi · Executive Officer, Director
  • Stephen Thau · Executive Officer
  • Carter Meyer · Director
  • David Badawi · Director
  • Mack Hicks · Director
  • Staffan Encrantz · Director
  • Valeska Schroeder · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jesse Selnick, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 10, 2019. Read the notice at the SEC.

equitySEC
Jul 2017$20 MNo. 2$10 to $50 million

Sight Sciences, Inc.: Raise no. 2, Jul 2017

Investors in this round

25 investors had bought by the notice of Jun 4, 2018: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Sight Sciences, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$20 M of $22 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jesse Selnick · Executive Officer
  • Paul Badawi · Executive Officer, Director
  • Carter Meyer · Director
  • David Badawi · Director
  • Mack Hicks · Director
  • Staffan Encrantz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Thau, Secretary. Source: SEC Form D and 1 amendment, newest notice filed Jun 4, 2018. Read the notice at the SEC.

equitySEC
Oct 2015$7 MNo. 1$2 to $10 million

Sight Sciences, Inc.: Raise no. 1, Oct 2015

Investors in this round

17 investors had bought by the notice of Oct 30, 2015: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 8 investors are named for Sight Sciences, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$7 M of $7 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Paul Badawi · Executive Officer, Director
  • Carter Meyer · Director
  • David Badawi · Director
  • Mack Hicks · Director
  • Tommy Hicks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Stephen Thau, Secretary. Source: SEC Form D, newest notice filed Oct 30, 2015. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Sight Sciences, Inc., its revenue in fiscal 2025 came from these business segments: Interventional Glaucoma $75.72 million (98%), Interventional Dry Eye $1.64 million (2%).

    Annual report (SEC XBRL) · Dec 2025

  • Sight Sciences, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2020).

    SEC Form D · Dec 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2020

Products and services#

No products or services of Sight Sciences, Inc. are on record.

Investors#

8 named in official filings. Open an investor to see everything it has backed.

Investors in Sight Sciences, Inc.
InvestorKindAmountRoundRoleSource
Andrew OfferPersonnot statednot statedHeld Series C preferred stock, director (Form 3, 2021)SEC Form 3
D1 Capital Partners L.P.Fund or asset managernot statednot statedHeld Series E and F preferred stock, 10% owner (Form 3, 2021)SEC Form 3
HEP Partners LLCFund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2021)SEC Form 3
HH-IOP Partners, L.P.Fund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2021)SEC Form 3
HH Sight LLCOthernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2021)SEC Form 3
HH Sight Partners GP, L.P.Fund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2021)SEC Form 3
HH Sight Partners, L.P.Fund or asset managernot statednot statedHeld Series A, B and C preferred stock, 10% owner (Form 3, 2021)SEC Form 3
KCK LTD.Companynot statednot statedHeld Series D preferred stock, 10% owner (Form 3, 2021)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 25 investors.

Largest shareholders today

Institutions holding Sight Sciences, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sight Sciences, Inc.
NameRoleNamed in
Jesse SelnickExecutive officerDec 2020
Paul BadawiExecutive officerDec 2020
Stephen ThauExecutive officerSep 2019
Andrew OfferDirectorDec 2020
David BadawiDirectorDec 2020
Don ZurbayDirectorDec 2020
Erica RogersDirectorDec 2020
Mack HicksDirectorDec 2020
Paul BadawiDirectorDec 2020
Staffan EncrantzDirectorDec 2020
Valeska SchroederDirectorDec 2020
Carter MeyerDirectorApr 2020
Tommy HicksDirectorOct 2015

Went public since 2021. Its SEC number is that of a company listed on a stock exchange.